Selective PPARγ antagonist (IC50 = 3.3, 32 and 2000 nM for PPARγ, PPARα and PPARδ respectively). Blocks the inhibition of osteoclast formation induced by IL-4 (1-2 μM). Displays anticancer activity inhibits growth of human mammary tumor cell lines. A useful tool for dissecting the involvement of...
Know who made it. See the evidence. Buy through one marketplace.
Selective PPARγ antagonist (IC50 = 3.3, 32 and 2000 nM for PPARγ, PPARα and PPARδ respectively). Blocks the inhibition of osteoclast formation induced by IL-4 (1-2 μM). Displays anticancer activity inhibits growth of human mammary tumor cell lines. A useful tool for dissecting the involvement of PPARγ in cellular physiology
This product is manufactured by TriBio Science and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
PPARG identifies peroxisome proliferator activated receptor gamma in Homo sapiens (Human). This target record connects NCBI Gene 5468, UniProtKB P37231 and related ABMIUM catalogue products.
